NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
09 September 2024
| Name: | EVE INVESTMENTS LIMITED (EVE) (This company subsequently changed its name to EVE HEALTH GROUP LIMITED. You should refer to that name for Status.) | |||||||||
| ISIN: | AU000000EVE3 | |||||||||
| Date of Listing: | 08 April 2004 | |||||||||
| Subsequent Names: |
| |||||||||
| Former Names: |
|
Stock Exchange Status: (updated daily)
This company subsequently changed its name to EVE HEALTH GROUP LIMITED. You should refer to that name for Stock Exchange Status.Legal Status: (updated monthly)
ACN: 106 523 611ABN: 89 106 523 611
Registration Date: 01 October 2003
Capital Gains Tax (CGT) Status: (updated at least quarterly)
This company subsequently changed its name and is now EVE HEALTH GROUP LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| EVE HEALTH GROUP LIMITED | 01/12/2021 | |
| EVE INVESTMENTS LIMITED | 04/12/2015 | 01/12/2021 |
| ENERGY VENTURES LTD | 07/10/2005 | 04/12/2015 |
| AUSTRALIAN DEVELOPMENT CAPITAL LIMITED | 07/10/2005 |
Link Market Services Perth
Level 12 QV1 Building 250 St Georges Terrace Perth WA 6000
Tel : +61 8 9211 6670 or 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail
Expand this box to read and print
name changed to Eve Health Group Limited | 01/12/2021 |
The suspension of trading in the securities of Eve Investments Limited will be lifted from the commencement of trading on Friday, 6 December 2019, following the release by EVE of an announcement regarding a capital raising. | 06/12/2019 |
First subscription funds of $2.4m have been received by the company. Shares to be allotted early next week. Funds used to expand Meluka Health and Jenbrook business activities. | 06/12/2019 |
At the company's 12 November 2019 AGM, shareholders passed a special resolution to amend the company's constitution. A copy of the constitution is then released to the market. | 04/12/2019 |
The securities of EVE Investments Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of EVE, pending the release of an announcement regarding a capital raising. | 29/11/2019 |
The suspension of trading in the securities of Eve Investments Limited will be lifted immediately, following the release by EVE of an announcement regarding a capital raising. | 07/10/2019 |
Subscription Deeds executed for a two stage share placement to strategic investment companies. First Subscription to raise $2.4m at 0.5 cents per share. Second Subscription to raise $6.9m at 1 cent per share. Funds used to expand Meluka Health and Jenbrook business activities. | 07/10/2019 |
The securities of EVE Investments Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of EVE, pending the release of an announcement regarding a capital raising. | 30/09/2019 |
The securities of Eve Investments Limited will be reinstated to official quotation immediately following the release of an announcement. | 06/10/2017 |
Firm commitments have been received for a $1.2m capital raising, including $110k of director participation. A $500k investment was made by an existing shareholder and Chinese pharmaceutical and traditional medicine group "“ TRT Investments Pty Ltd. Funds will be used to complete the Meluka Health investment. | 06/10/2017 |
The Company is continuing discussions with key parties and expects to resolve the capital raising within the week. | 02/10/2017 |
The securities of Eve Investments Limited will be suspended from official quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising | 27/09/2017 |
The suspension of trading in the securities of Eve Investments Limited will be lifted immediately, following the release by the Company of an announcement regarding a capital raising and an acquisition. | 02/05/2017 |
The company has entered into an agreement to acquire a 50% interest in an established organic essential oils producer from Jenbrook Pty Ltd whose long"term owner is Bryan Easson, for total consideration of $1.49m. | 01/05/2017 |
The company lodges its Appendix 4C - Quarterly Report. | 28/04/2017 |
The company is still progressing discussions with potential investors in relation to the capital raising to fund the second tranche investment into Omni Innovation. The requirement to invest a further $625,000 into Omni Innovation has been deferred from 31 March 2017 to 30 April 2017 to allow time for EVE to complete the capital raising process. EVE is in the final stages of negotiating a new investment opportunity. | 21/04/2017 |
The Company is still progressing discussions with potential investors in relation to the capital raising and will provide shareholders with a further update by Monday, 24 April 2017. | 18/04/2017 |
EVE Investments gives notice that the unaudited Net Tangible Assets (NTA) per share as at 31 March 2017 was $0.0017 per share. | 13/04/2017 |
The company provides an update on the progress of the capital raising that is being conducted to complete the second tranche investment into Omni Innovation. The Company is still progressing discussions with potential investors in relation to the capital raising and will provide shareholders with an update by Tuesday, 18 April 2017. | 10/04/2017 |
The company would like to update shareholders on the progress of the capital raising that is being conducted to complete the second tranche investment into Omni Innovation. The Company is continuing discussions with potential investors and expects to resolve the capital raising within the week. A further announcement will be provided to shareholders in due course, at which point the voluntary suspension will be lifted. | 03/04/2017 |
The securities of EVE Investments Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising. | 27/03/2017 |
The suspension of trading in the securities of EVE Investments Limited will be lifted before the commencement of trading on Wednesday, 28 December 2016, following the release by the Company of an announcement regarding a capital raising. | 23/12/2016 |
EVE Investments, an ASX-listed technology investment company, is pleased to announce a two-tranche placement to raise up to $1.6m at $0.008. | 23/12/2016 |
EVE Investments gives notice that the unaudited Net Tangible Assets (NTA) per share as at 30 November 2016 was $0.0018 per share. | 22/12/2016 |
EVE Investments advises that the non-renounceable entitlement issue which closed on 6 December 2016 raised less than the minimum funds required under the Offer Document. Accordingly, the entitlement issue has been withdrawn and funds will be returned to applicants on 16 December 2016. EVE is continuing to pursue other capital raising initiatives and expects to update the market on these activities by Monday 19 December 2016, at which time the voluntary suspension will be lifted. | 14/12/2016 |
The securities of EVE Investments Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising. | 14/12/2016 |
The suspension of trading in the securities of Eve Investments Limited will be lifted immediately, following the release by the Company of an announcement regarding a capital raising. | 10/11/2016 |
EVE will conduct a placement at 1 cent per share to raise $600,000 before costs by issuing 60,000,000 new shares to a new strategic investor, the Tianjin Tongrentang Group via its Australian subsidiary TRT Investment Group. n addition to the placement, EVE will also be offering existing shareholders the opportunity to participate in a non-renounceable entitlement issue at the same price as the placement on a 1:6 basis raising up to $1,959,167. The entitlement issue will be managed by Westar Capital Ltd. | 10/11/2016 |
The securities of Eve Investments Limited will be suspended from official quotation immediately at the request of the Company, pending the release of an announcement in relation to a capital raising. | 03/11/2016 |
name changed from Energy Ventures Limited | 04/12/2015 |
name changed to Eve Health Group Limited | 01/12/2021 |
The suspension of trading in the securities of Eve Investments Limited will be lifted from the commencement of trading on Friday, 6 December 2019, following the release by EVE of an announcement regarding a capital raising. | 06/12/2019 |
First subscription funds of $2.4m have been received by the company. Shares to be allotted early next week. Funds used to expand Meluka Health and Jenbrook business activities. | 06/12/2019 |
At the company's 12 November 2019 AGM, shareholders passed a special resolution to amend the company's constitution. A copy of the constitution is then released to the market. | 04/12/2019 |
The securities of EVE Investments Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of EVE, pending the release of an announcement regarding a capital raising. | 29/11/2019 |
The suspension of trading in the securities of Eve Investments Limited will be lifted immediately, following the release by EVE of an announcement regarding a capital raising. | 07/10/2019 |
Subscription Deeds executed for a two stage share placement to strategic investment companies. First Subscription to raise $2.4m at 0.5 cents per share. Second Subscription to raise $6.9m at 1 cent per share. Funds used to expand Meluka Health and Jenbrook business activities. | 07/10/2019 |
The securities of EVE Investments Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of EVE, pending the release of an announcement regarding a capital raising. | 30/09/2019 |
The securities of Eve Investments Limited will be reinstated to official quotation immediately following the release of an announcement. | 06/10/2017 |
Firm commitments have been received for a $1.2m capital raising, including $110k of director participation. A $500k investment was made by an existing shareholder and Chinese pharmaceutical and traditional medicine group "“ TRT Investments Pty Ltd. Funds will be used to complete the Meluka Health investment. | 06/10/2017 |
The Company is continuing discussions with key parties and expects to resolve the capital raising within the week. | 02/10/2017 |
The securities of Eve Investments Limited will be suspended from official quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising | 27/09/2017 |
The suspension of trading in the securities of Eve Investments Limited will be lifted immediately, following the release by the Company of an announcement regarding a capital raising and an acquisition. | 02/05/2017 |
The company has entered into an agreement to acquire a 50% interest in an established organic essential oils producer from Jenbrook Pty Ltd whose long"term owner is Bryan Easson, for total consideration of $1.49m. | 01/05/2017 |
The company lodges its Appendix 4C - Quarterly Report. | 28/04/2017 |
The company is still progressing discussions with potential investors in relation to the capital raising to fund the second tranche investment into Omni Innovation. The requirement to invest a further $625,000 into Omni Innovation has been deferred from 31 March 2017 to 30 April 2017 to allow time for EVE to complete the capital raising process. EVE is in the final stages of negotiating a new investment opportunity. | 21/04/2017 |
The Company is still progressing discussions with potential investors in relation to the capital raising and will provide shareholders with a further update by Monday, 24 April 2017. | 18/04/2017 |
EVE Investments gives notice that the unaudited Net Tangible Assets (NTA) per share as at 31 March 2017 was $0.0017 per share. | 13/04/2017 |
The company provides an update on the progress of the capital raising that is being conducted to complete the second tranche investment into Omni Innovation. The Company is still progressing discussions with potential investors in relation to the capital raising and will provide shareholders with an update by Tuesday, 18 April 2017. | 10/04/2017 |
The company would like to update shareholders on the progress of the capital raising that is being conducted to complete the second tranche investment into Omni Innovation. The Company is continuing discussions with potential investors and expects to resolve the capital raising within the week. A further announcement will be provided to shareholders in due course, at which point the voluntary suspension will be lifted. | 03/04/2017 |
The securities of EVE Investments Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising. | 27/03/2017 |
The suspension of trading in the securities of EVE Investments Limited will be lifted before the commencement of trading on Wednesday, 28 December 2016, following the release by the Company of an announcement regarding a capital raising. | 23/12/2016 |
EVE Investments, an ASX-listed technology investment company, is pleased to announce a two-tranche placement to raise up to $1.6m at $0.008. | 23/12/2016 |
EVE Investments gives notice that the unaudited Net Tangible Assets (NTA) per share as at 30 November 2016 was $0.0018 per share. | 22/12/2016 |
EVE Investments advises that the non-renounceable entitlement issue which closed on 6 December 2016 raised less than the minimum funds required under the Offer Document. Accordingly, the entitlement issue has been withdrawn and funds will be returned to applicants on 16 December 2016. EVE is continuing to pursue other capital raising initiatives and expects to update the market on these activities by Monday 19 December 2016, at which time the voluntary suspension will be lifted. | 14/12/2016 |
The securities of EVE Investments Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising. | 14/12/2016 |
The suspension of trading in the securities of Eve Investments Limited will be lifted immediately, following the release by the Company of an announcement regarding a capital raising. | 10/11/2016 |
EVE will conduct a placement at 1 cent per share to raise $600,000 before costs by issuing 60,000,000 new shares to a new strategic investor, the Tianjin Tongrentang Group via its Australian subsidiary TRT Investment Group. n addition to the placement, EVE will also be offering existing shareholders the opportunity to participate in a non-renounceable entitlement issue at the same price as the placement on a 1:6 basis raising up to $1,959,167. The entitlement issue will be managed by Westar Capital Ltd. | 10/11/2016 |
The securities of Eve Investments Limited will be suspended from official quotation immediately at the request of the Company, pending the release of an announcement in relation to a capital raising. | 03/11/2016 |
name changed from Energy Ventures Limited | 04/12/2015 |
Your browser may reflect a date of printing in American format.
This company is so far under the radar, has the Omnibelnd product, under the Fauldings label, first class distribution company and product ready to hit the shelvess with advertizing blitz ciming very soon | 10/05/2016 14:15:19 |
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 25/11/2021 | Gregory Fry | 1,787,235 | $0.004 | $7,149 |
| 21/05/2020 | Gregory Fry | 4,000,000 | $0.006 | $22,000 |
| 08/11/2018 | Gregory Fry | 2,000,000 | $0.007 | $14,165 |
| 12/01/2017 | Gregory Fry | 1,500,000 | $0.007 | $10,500 |
| 18/05/2012 | Alasdair Cooke | 2,000,000 | $0.023 | $46,506 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| George Cameron-Dow | Non Exec Chairman | 31/03/2016 |
| Gregory Fry | Managing Director, CEO | 18/08/2009 |
| Ben Rohr | COO | 10/12/2019 |
| Alasdair Cooke | Non Exec Director | 08/01/2007 |
| James Lin | Director | 22/04/2021 |
| Carlos Jin | Director | 10/12/2019 |
| Steven Jackson | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Joalin Chou | Director | 21/01/2020 | 22/04/2021 |
| Michael Pixley | Non Exec Director | 16/10/2017 | 30/06/2020 |
| Michael Curnow | Non Exec Director | 27/04/2006 | 31/03/2016 |
| Lachlan Reynolds | Managing Director | 20/12/2010 | 11/09/2012 |
| Ian J. Duncan | Executive Chairman | 07/10/2005 | 25/11/2010 |
| Brett Mitchell | Executive Director | 30/09/2004 | 31/05/2009 |
| Claire Poll | Non Exec Director | 18/08/2004 | 29/04/2006 |
| Michael Blakiston | Chairman | 01/10/2003 | 12/10/2005 |
| Gary Steinepreis | Director | 01/10/2003 | 01/10/2004 |
| Anthony Kain | Non Exec Director | 19/11/2003 | 20/08/2004 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
